Total Payments
$9,024
2024 Payments
$1,207
Companies
25
Transactions
504
Medicare Patients
1,140
Medicare Billing
$279,595
Payment Breakdown by Category
Food & Beverage$8,834 (97.9%)
Education$190.00 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,834 | 496 | 97.9% |
| Education | $190.00 | 8 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,190 | 72 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $978.15 | 43 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $961.62 | 47 | $0 (2024) |
| Lundbeck LLC | $848.03 | 45 | $0 (2024) |
| ABBVIE INC. | $769.17 | 52 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $658.60 | 25 | $0 (2022) |
| Alkermes, Inc. | $591.94 | 30 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $541.88 | 33 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $503.49 | 29 | $0 (2024) |
| ITI, Inc. | $441.40 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,207 | 53 | Supernus Pharmaceuticals, Inc. ($219.79) |
| 2023 | $1,238 | 56 | Otsuka America Pharmaceutical, Inc. ($238.57) |
| 2022 | $1,016 | 47 | Teva Pharmaceuticals USA, Inc. ($230.56) |
| 2021 | $1,559 | 80 | Takeda Pharmaceuticals U.S.A., Inc. ($380.93) |
| 2020 | $1,180 | 65 | Janssen Pharmaceuticals, Inc ($236.43) |
| 2019 | $1,181 | 96 | Janssen Pharmaceuticals, Inc ($192.53) |
| 2018 | $944.65 | 60 | Janssen Pharmaceuticals, Inc ($232.87) |
| 2017 | $698.07 | 47 | Janssen Pharmaceuticals, Inc ($160.78) |
All Payment Transactions
504 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $21.08 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: Neuropsychiatry | ||||||
| 10/14/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $16.84 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Central Nervous System | ||||||
| 09/11/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $12.98 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.62 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $45.04 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $41.37 | General |
| Category: Neuroscience | ||||||
| 08/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Neurology | ||||||
| 08/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Central Nervous System | ||||||
| 08/08/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/08/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $1.19 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/06/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: Neurology | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: PSYCHIATRY | ||||||
| 07/02/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 267 | 857 | $152,155 | $71,624 |
| 2022 | 6 | 300 | 917 | $151,131 | $77,301 |
| 2021 | 7 | 354 | 782 | $132,924 | $69,547 |
| 2020 | 5 | 219 | 863 | $144,917 | $61,123 |
Total Patients
1,140
Total Services
3,419
Medicare Billing
$279,595
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 22 | 185 | $48,311 | $20,721 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 212 | $39,364 | $19,761 | 50.2% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 55 | 214 | $23,814 | $11,236 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 118 | $15,093 | $8,050 | 53.3% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 29 | 90 | $15,361 | $6,641 | 43.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 23 | $5,496 | $2,952 | 53.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 15 | 15 | $4,716 | $2,262 | 48.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 234 | $40,014 | $21,482 | 53.7% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 28 | 174 | $41,450 | $19,599 | 47.3% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 71 | 255 | $26,265 | $13,128 | 50.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 89 | $20,381 | $12,027 | 59.0% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 36 | 92 | $14,480 | $6,563 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 73 | $8,541 | $4,500 | 52.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 65 | 167 | $38,243 | $23,282 | 60.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 179 | $30,609 | $15,317 | 50.0% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 19 | 85 | $20,249 | $9,732 | 48.1% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 76 | 168 | $17,304 | $8,794 | 50.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 103 | $12,051 | $5,853 | 48.6% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 38 | 57 | $8,971 | $4,088 | 45.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 23 | 23 | $5,497 | $2,480 | 45.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 91 | 407 | $69,597 | $27,334 | 39.3% |
| 90837 | Psychotherapy, 60 minutes | Office | 2020 | 25 | 169 | $40,259 | $17,969 | 44.6% |
| 90832 | Psychotherapy, 30 minutes | Office | 2020 | 60 | 174 | $17,922 | $8,710 | 48.6% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 29 | 97 | $15,267 | $6,429 | 42.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 16 | $1,872 | $681.51 | 36.4% |
About Dr. Daniel Storch, MD
Dr. Daniel Storch, MD is a Psychiatry healthcare provider based in Columbia, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790740413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Storch, MD has received a total of $9,024 in payments from pharmaceutical and medical device companies, with $1,207 received in 2024. These payments were reported across 504 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($8,834).
As a Medicare-enrolled provider, Storch has provided services to 1,140 Medicare beneficiaries, totaling 3,419 services with total Medicare billing of $279,595. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Columbia, MD
- Active Since 04/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1790740413
Products in Payments
- VRAYLAR (Drug) $1,115
- INVEGA SUSTENNA (Drug) $1,056
- REXULTI (Drug) $1,028
- TRINTELLIX (Drug) $563.80
- ABILIFY MAINTENA (Drug) $562.89
- LATUDA (Drug) $541.88
- INGREZZA (Drug) $503.49
- CAPLYTA (Drug) $490.03
- AUSTEDO (Drug) $452.35
- ARISTADA (Drug) $415.24
- Qelbree (Drug) $219.79
- Austedo XR (Drug) $201.53
- Fanapt (Drug) $197.41
- UZEDY (Drug) $182.97
- VYVANSE (Drug) $170.14
- NUEDEXTA (Drug) $130.57
- ABILIFY ASIMTUFII (Drug) $120.03
- Aristada 441 mg (Drug) $111.33
- BRINTELLIX (Drug) $98.09
- HETLIOZ (Drug) $82.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Columbia
Dr. Meera Narasimhan, M.d, M.D
Psychiatry — Payments: $57,045
Psychiatry $57,045
Dr. Joseph Parks, M.d, M.D
Psychiatry — Payments: $53,504
Psychiatry $53,504
Agara Reddy, Md, MD
Psychiatry — Payments: $15,068
Psychiatry $15,068
Deborah Leverette, Md Mph, MD MPH
Psychiatry — Payments: $12,750
Psychiatry $12,750
Gariane Gunter, M.d, M.D
Psychiatry — Payments: $11,480
Psychiatry $11,480
Dr. Nioaka Campbell, M.d, M.D
Psychiatry — Payments: $10,898
Psychiatry $10,898